BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7907249)

  • 21. t(12;17)(p13;q21) in early pre-B acute lymphoid leukemia.
    Krance RA; Raimondi SC; Dubowy R; Estrada J; Borowitz M; Behm F; Land VJ; Pullen J; Carroll AJ
    Leukemia; 1992 Apr; 6(4):251-5. PubMed ID: 1534130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
    Raponi S; De Propris MS; Intoppa S; Milani ML; Vitale A; Elia L; Perbellini O; Pizzolo G; Foá R; Guarini A
    Leuk Lymphoma; 2011 Jun; 52(6):1098-107. PubMed ID: 21348573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
    Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
    Leuk Lymphoma; 2001 Jun; 42(1-2):75-82. PubMed ID: 11699224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences of immunologic phenotyping in acute leukemia].
    Brinch L; Evensen SA; Stavem P; Smeland EB
    Tidsskr Nor Laegeforen; 1989 Feb; 109(4):443-6. PubMed ID: 2919374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
    Li X; Du W; Liu W; Li X; Li H; Huang SA
    APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of myeloid antigens in acute lymphoblastic leukaemia.
    Howard MR; Reid MM
    Br J Haematol; 1994 Dec; 88(4):897-8. PubMed ID: 7819119
    [No Abstract]   [Full Text] [Related]  

  • 28. CD99 (p30/32MIC2) immunoreactivity in the diagnosis of leukemia cutis.
    Dorfman DM; Kraus M; Perez-Atayde AR; Barnhill RL; Pinkus GS; Granter SR
    Mod Pathol; 1997 Apr; 10(4):283-8. PubMed ID: 9110288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O; Glasová M; Koníková E; Kusenda J
    Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid antigen positivity in Turkish children with acute lymphoblastic leukemia lacks influence on prognosis.
    Tanyeli A; Erbey F; Bayram I; Kömür M
    Asian Pac J Cancer Prev; 2010; 11(6):1823-6. PubMed ID: 21338240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hybrid leukemia among acute childhood leukemias].
    Koehler M; Bubała H
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):347-9. PubMed ID: 1437751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtype.
    Ferrero D; Carlesso N; Gallo E; Pregno P; De Fabritiis P; Petti MC; Mandelli F
    Leuk Res; 1991; 15(6):457-61. PubMed ID: 1861531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.
    Li WV; Kapadia SB; Sonmez-Alpan E; Swerdlow SH
    Mod Pathol; 1996 Oct; 9(10):982-8. PubMed ID: 8902835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristic analysis of acute leukemia immunophenotyping in 180 cases by flow cytometry].
    Yao ZJ; Liao L; Dang YH; Zhang J; Tian Y; Feng K; Qi CY; Wang JF; Chen H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):83-5. PubMed ID: 14989776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cells antigens' expression modulation during induction treatment of childhood acute lymphoblastic leukemia].
    Pawińska-Wasikowska K; Balwierz W
    Przegl Lek; 2010; 67(6):361-5. PubMed ID: 21344762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of peroxidase negative acute leukemias by monoclonal antibodies: III. Acute lymphoblastic leukemia.
    Imamura N; Kuramoto A
    J Clin Lab Anal; 1989; 3(2):88-94. PubMed ID: 2659759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage.
    Hoyer JD; Grogg KL; Hanson CA; Gamez JD; Dogan A
    Am J Clin Pathol; 2008 Feb; 129(2):316-23. PubMed ID: 18208813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia.
    Pui CH; Behm FG; Crist WM
    Blood; 1993 Jul; 82(2):343-62. PubMed ID: 8329694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.
    Childs CC; Hirsch-Ginsberg C; Walters RS; Andersson BS; Reuben J; Trujillo JM; Cork A; Stass SA; Freireich EJ; Zipf TF
    Leukemia; 1989 Nov; 3(11):777-83. PubMed ID: 2811478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.